Evidence map›Paper›PMID 25423036›Full record

ArticlePloS one2014

Sleeping Beauty mouse models identify candidate genes involved in gliomagenesis.

Irina Vyazunova, Vilena I Maklakova, Samuel Berman, Ishani De, Megan D Steffen, Won Hong, Hayley Lincoln, A Sorana Morrissy, Michael D Taylor, Keiko Akagi and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Irina VyazunovaSchool of Pharmacy and University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, Madison, WI, United States of America.
Vilena I MaklakovaSchool of Pharmacy and University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, Madison, WI, United States of America.
Samuel BermanHuman Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Ishani DeSchool of Pharmacy and University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, Madison, WI, United States of America.
Megan D SteffenSchool of Pharmacy and University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, Madison, WI, United States of America.
Won HongSchool of Pharmacy and University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, Madison, WI, United States of America.
Hayley LincolnSchool of Pharmacy and University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, Madison, WI, United States of America.
A Sorana MorrissyDivision of Neurosurgery, Arthur & Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.
Michael D TaylorDivision of Neurosurgery, Arthur & Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.
Keiko AkagiComprehensive Cancer Center, The Ohio State University, Columbus, OH, United States of America.
Cameron W BrennanHuman Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Fausto J RodriguezDepartment of Pathology, Division of Neuropathology, Johns Hopkins University, Baltimore, MD, United States of America.
Lara S CollierSchool of Pharmacy and University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, Madison, WI, United States of America.
University of Wisconsin–Madison · USMemorial Sloan Kettering Cancer Center · USUniversity of Wisconsin Carbone Cancer Center · USHospital for Sick Children · CAJohns Hopkins University · USSickKids Foundation · CAThe Ohio State University · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Transgenic Mouse and Biobank CoreP01CA095616 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DEPINHO, RONALD ANTHONY · 2003 to 2012
$20.3M
Alabama Neuroscience Blueprint Core CenterP30NS057098 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SWEATT, JOHN DAVID · 2006 to 2010
$9.5M
ANALYSES AND APPLICATIONS OF GLIAL FIBRILLARY ACIDIC PROR01NS039055 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRENNER, MICHAEL · 1999 to 2010
$2.6M
CSF1 signaling in gliomagenesisR01NS085364 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI COLLIER, LARA S · 2014 to 2019
$1.6M
A Forward Genetic Approach To Studying Glioma Formation and Therapy ResistanceR21NS065352 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI COLLIER, LARA S · 2009 to 2010
$405k
NCI NIH HHS P01 CA095616NCI NIH HHS P01-CA95616NCI NIH HHS P30 CA014520NCI NIH HHS P30-CA014520NINDS NIH HHS NS057098NINDS NIH HHS NS39055NINDS NIH HHS P30 NS057098NINDS NIH HHS R01 NS039055NINDS NIH HHS R01 NS085364NINDS NIH HHS R01-NS085364NINDS NIH HHS R21 NS065352NINDS NIH HHS R21-NS65352
6 · The paper itself

Abstract

Genomic studies of human high-grade gliomas have discovered known and candidate tumor drivers. Studies in both cell culture and mouse models have complemented these approaches and have identified additional genes and processes important for gliomagenesis. Previously, we found that mobilization of Sleeping Beauty transposons in mice ubiquitously throughout the body from the Rosa26 locus led to gliomagenesis with low penetrance. Here we report the characterization of mice in which transposons are mobilized in the Glial Fibrillary Acidic Protein (GFAP) compartment. Glioma formation in these mice did not occur on an otherwise wild-type genetic background, but rare gliomas were observed when mobilization occurred in a p19Arf heterozygous background. Through cloning insertions from additional gliomas generated by transposon mobilization in the Rosa26 compartment, several candidate glioma genes were identified. Comparisons to genetic, epigenetic and mRNA expression data from human gliomas implicates several of these genes as tumor suppressor genes and oncogenes in human glioblastoma.

Indexed as

DNA Transposable ElementsAnimalsBase SequenceBrain NeoplasmsDNA PrimersGlial Fibrillary Acidic ProteinGliomaMicePolymerase Chain ReactionTransposasesDNA PrimersDNA Transposable ElementsGlial Fibrillary Acidic ProteinTransposases

Identifiers

PMID25423036
PMCPMC4244117
OpenAlexW2095477656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.